A trial of MRI-targeted prostate biopsy compared cognitive fusion and software-based fusion for detection of clinically significant prostate cancer.
Defense Secretary Pete Hegseth announced that the U.S. military will begin annual screening for testosterone deficiency among service members ages 30 and older. Testosterone repla ...
Objective: This study aimed to comprehensively evaluate the diagnostic performance of magnetic resonance imaging (MRI)–based AI models in predicting biochemical recurrence (BCR) of PCa. Methods: ...
Patients with advanced prostate cancer may need periodic imaging scans to catch tumor growth even with stable levels of prostate-specific antigen (PSA), a protein in the blood that doctors routinely ...
Prostate-specific antigen (PSA) testing to screen for prostate cancer is controversial. An alternative approach, Stockholm3, combines PSA, plasma protein biomarkers, polygenic risk, and clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results